⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL498033 | 0.61 | — | — | |
| SCHEMBL223205 | 0.60 | — | — | |
| SCHEMBL2230333 | 0.59 | — | — | |
| SCHEMBL9665002 | 0.59 | — | — | |
| SCHEMBL4892384 | 0.59 | — | — | |
| SCHEMBL4371910 | 0.57 | — | — | |
| SCHEMBL11105462 | 0.56 | — | — | |
| SCHEMBL353445 | 0.56 | PTPRC (0.31) | — | |
| SCHEMBL447698 | 0.56 | — | — | |
| SCHEMBL18032691 | 0.56 | GSK3A (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016054807-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. (US) | 2016-04-14 | — | — | WO | claimed |
| JP-4838934-B2 | — | — | 2011-12-14 | — | — | JP | claimed |
| WO-2007014054-A2 | BENZENESULFONAMIDE INHIBITOR OF CCR2 CHEMOKINE RECEPTOR | GLAXO GROUP LIMTED (GB) | 2007-02-01 | — | — | WO | claimed |
| EP-1042291-B1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE CO CHEM PHARM FAB (DE) | 2005-07-13 | — | — | EP | claimed |
| US-6200961-B1 | FREE OF VOLATILE ORGANIC COMPOUNDS, STABILITY; FOR CONTROLLING INSECTS | AQUATROLS CORPORATION OF AMERICA, INC. | 2001-03-13 | — | — | US | claimed |
| EP-1043927-A1 | AGROCHEMICAL EMULSIFIABLE CONCENTRATES | Aquatrols Holding Co., Inc. (US) | 2000-10-18 | — | — | EP | claimed |
| EP-1042291-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | claimed |
| WO-1999033340-A1 | AGROCHEMICAL EMULSIFIABLE CONCENTRATES | AQUATROLS HOLDING CO., INC. (US) | 1999-07-08 | — | — | WO | claimed |
| WO-1999031064-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | claimed |
| EP-2137162-B1 | ORGANIC COMPOUNDS AND THEIR USES | NOVARTIS AG (CH) | 2018-08-01 | — | — | EP | disclosed |
| WO-2016054807-A1 | TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF | MERCK SHARP & DOHME CORP. (US) | 2016-04-14 | — | — | WO | disclosed |
| EP-2946014-A2 | SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES | Moderna Therapeutics, Inc. (US) | 2015-11-25 | — | — | EP | disclosed |
| EP-2931914-A1 | MODIFIED POLYNUCLEOTIDES FOR ALTERING CELL PHENOTYPE | Moderna Therapeutics, Inc. (US) | 2015-10-21 | — | — | EP | disclosed |
| EP-2793906-A2 | METHODS OF INCREASING THE VIABILITY OR LONGEVITY OF AN ORGAN OR ORGAN EXPLANT | Moderna Therapeutics, Inc. (US) | 2014-10-29 | — | — | EP | disclosed |
| EP-1079832-A1 | USE OF VITAMIN PP COMPOUNDS | Klinge Pharma GmbH (DE) | 2001-03-07 | — | — | EP | disclosed |
| EP-1043927-A1 | AGROCHEMICAL EMULSIFIABLE CONCENTRATES | Aquatrols Holding Co., Inc. (US) | 2000-10-18 | — | — | EP | disclosed |
| EP-1042291-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | Klinge Pharma GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999053920-A1 | USE OF VITAMIN PP COMPOUNDS | KLINGE PHARMA GMBH (DE) | 1999-10-28 | — | — | WO | disclosed |
| WO-1999033340-A1 | AGROCHEMICAL EMULSIFIABLE CONCENTRATES | AQUATROLS HOLDING CO., INC. (US) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999031064-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |